天美传媒

Jump to Main Content

Advocacy

Resources for Sickle Cell Disease Pain Management

ASH is committed to addressing issues related to pain management in the care of individuals living with sickle cell disease (SCD) by providing information and resources from vested stakeholder groups.

Policy and News

The latest legislative and policy work regarding the management of pain in the SCD treatment space.

  • CDC Issues Key Clarification on Guideline for Prescribing Opioids for Chronic Pain
    Joint statement by the 天美传媒 Society of Hematology (ASH), 天美传媒 Society of Clinical Oncology (ASCO), and National Comprehensive Cancer Network (NCCN) on guideline clarification by the Centers for Disease Control and Prevention (CDC)

  • U.S. Department of Health and Human Services Pain Management Best Practices Inter-Agency Task Force Report on Acute and Chronic Pain Management; SCD provisions can be found in the Special Populations section of the report

  • 2020 Medicare Advantage and Part D Rate Announcement and Final Call Letter Fact Sheet, in which the Centers for Medicare and Medicaid Services recommends beneficiaries with SCD be excluded from opioid safety edits
  • ASH Statement on Opioid Use in Patients with Hematologic Diseases and Disorders
    ASH statement on potential adverse effects that policy changes could have on the administration of necessary and appropriate pain medicine for patients with hematologic conditions such as SCD, blood cancers, and other bleeding disorders

Clinical Resources

Resources to assist practitioners in providing excellent quality of care in the treatment of SCD.

Articles

Questions?

If you have questions or comments regarding the information on this page, please contact Shant谩 Robertson, Manager, Sickle Cell Disease Programs at [email protected].